Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för SU6656. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

10 träffar

Bibliografisk träff 2013-11-22

Dual inhibition of Src family kinases and Aurora kinases by SU6656 modulates CTGF (connective tissue growth factor) expression in an ERK-dependent manner.

Cicha I, Zitzmann R, Goppelt-Struebe M.

Int J Biochem Cell Biol · journal article · DOI 10.1016/j.biocel.2013.11.014

Bibliografisk träff 2013-02-05

Inhibition of p21 and Akt potentiates SU6656-induced caspase-independent cell death in FRO anaplastic thyroid carcinoma cells.

Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG, Yoo HJ, Lee SJ.

Horm Metab Res · research support, non-u.s. gov't; journal article · DOI 10.1055/s-0033-1333716

Bibliografisk träff 2013-01-01

Inhibition of mTORC1 by SU6656, the selective Src kinase inhibitor, is not accompanied by activation of Akt/PKB signalling in melanoma cells.

Ondrušová L, Réda J, Záková P, Tuháčková Z.

Folia Biol (Praha) · research support, non-u.s. gov't; journal article · DOI 10.14712/fb2013059040162

Bibliografisk träff 2012-01-13

Simultaneous inhibition of Src and Aurora kinases by SU6656 induces therapeutic synergy in human synovial sarcoma growth, invasion and angiogenesis in vivo.

Arai R, Tsuda M, Watanabe T, Ose T, Obuse C, Maenaka K, Minami A, Ohba Y.

Eur J Cancer · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejca.2011.12.028

Bibliografisk träff 2011-11-18

SU-6656, a selective Src kinase inhibitor, attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice.

Rehni AK, Singh TG, Arora S.

Nicotine Tob Res · research support, non-u.s. gov't; journal article · DOI 10.1093/ntr/ntr228

Bibliografisk träff 2011-10-27

Plasmodium induced by SU6656, an Src family kinase inhibitor, is accompanied by a contractile ring defect.

Yoshida K, Ono M, Bito H, Mikami T, Sawada H.

Cell Biochem Funct · research support, non-u.s. gov't; journal article · DOI 10.1002/cbf.1814

Bibliografisk träff 2006-03-01

SRC family kinase inhibitor SU6656 enhances antiangiogenic effect of irradiation.

Cuneo KC, Geng L, Tan J, Brousal J, Shinohara ET, Osusky K, Fu A, Shyr Y, Wu H, Hallahan DE.

Int J Radiat Oncol Biol Phys · journal article; research support, n.i.h., extramural · DOI 10.1016/j.ijrobp.2005.11.014

Bibliografisk träff 2005-06-28

SRC family kinase activity is required for murine embryonic stem cell growth and differentiation.

Meyn MA, Schreiner SJ, Dumitrescu TP, Nau GJ, Smithgall TE.

Mol Pharmacol · research support, u.s. gov't, p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1124/mol.104.010231

Bibliografisk träff 2005-01-27

Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656.

Lannutti BJ, Blake N, Gandhi MJ, Reems JA, Drachman JG.

Blood · research support, u.s. gov't, p.h.s.; research-article; journal article; research support, n.i.h., extramural · DOI 10.1182/blood-2004-10-3934

Bibliografisk träff 2000-12-01

SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling.

Blake RA, Broome MA, Liu X, Wu J, Gishizky M, Sun L, Courtneidge SA.

Mol Cell Biol · research-article; journal article · DOI 10.1128/mcb.20.23.9018-9027.2000